Heartland Advisors released its third-quarter 2025 investor letter, showing robust performance for small caps. The Russell 2000® Index was up 12.39%, outperforming the S&P 500 Index. The Heartland Value Plus Fund returned 8.51% in the quarter. Prestige Consumer Healthcare Inc. (NYSE: PBH) was highlighted in the letter, with a one-month return of -3.13% and a market capitalization of $3.002 billion.

In the investor letter, Heartland Value Plus Fund mentioned that Prestige Consumer Healthcare Inc. (NYSE: PBH) was the biggest detractor to their performance due to missed earnings forecasts and supply chain issues. The stock closed at $61.00 per share on October 10, 2025. Despite this, Prestige Consumer Healthcare Inc. (NYSE: PBH) was not among the 30 Most Popular Stocks Among Hedge Funds.

Prestige Consumer Healthcare Inc. (NYSE: PBH) reported revenue of $249.5 million in the fiscal first quarter of 2026, down from $267.1 million the previous year. While acknowledging its potential, Heartland Advisors believes certain AI stocks offer greater upside potential. They recommend checking out a free report on the best short-term AI stock for more information.

Read more at Yahoo Finance: Here’s Heartland Value Plus Fund’s Views on Prestige Consumer Healthcare (PBH)